Antimicrobial stewardship in the Federal Bureau of Prisons: Combining prospective audit and feedback with formulary changes to reduce inappropriate fluoroquinolone use

被引:0
作者
Brorby, Alexander [1 ,2 ]
Herring, Holly [3 ]
Williams, Evan [4 ,5 ]
机构
[1] Fed Correct Complex Florence, Florence, CO 81226 USA
[2] United States Publ Hlth Serv, Commissioned Corps, Washington, DC 20245 USA
[3] Fed Correct Inst Schuylkill, Minersville, PA USA
[4] Roseman Univ Hlth Sci, Coll Pharm, Henderson, NV USA
[5] United States Publ Hlth Serv, Reserve Commissioned Corps, Washington, DC USA
关键词
ambulatory care; antibacterial agents; antimicrobial stewardship; correctional health; fluoroquinolone;
D O I
10.1093/ajhp/zxae394
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose Antimicrobial stewardship programs have been widely implemented with positive results in the inpatient healthcare delivery model. However, data supporting these interventions is limited in other care settings. Summary Formulary restrictions and conducting prospective audit and feedback (PAF) are mainstays of antimicrobial stewardship. A PAF program targeted specifically at fluoroquinolone use was implemented in the Federal Bureau of Prisons (FBOP), in addition to exclusionary formulary restrictions on ciprofloxacin and levofloxacin. After implementation of these interventions, overall fluoroquinolone orders per 1,000 adults in custody (AICs) were reduced by 46.4% (P < 0.0001). The majority of PAF interventions addressed situations in which an antibiotic was unnecessary or a fluoroquinolone was not the recommended first-line agent. Over the same time period, nonformulary approval rates for ciprofloxacin and levofloxacin averaged 62%. Conclusion The interventions from this program provide data supporting the effectiveness of formulary changes and PAF for antimicrobial stewardship in a nontraditional care setting.
引用
收藏
页数:5
相关论文
共 10 条
[1]  
[Anonymous], 2011, ANTIMICROBIAL RESIST
[2]   Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America [J].
Barlam, Tamar F. ;
Cosgrove, Sara E. ;
Abbo, Lilian M. ;
MacDougall, Conan ;
Schuetz, Audrey N. ;
Septimus, Edward J. ;
Srinivasan, Arjun ;
Dellit, Timothy H. ;
Falck-Ytter, Yngve T. ;
Fishman, Neil O. ;
Hamilton, Cindy W. ;
Jenkins, Timothy C. ;
Lipsett, Pamela A. ;
Malani, Preeti N. ;
May, Larissa S. ;
Moran, Gregory J. ;
Neuhauser, Melinda M. ;
Newland, Jason G. ;
Ohl, Christopher A. ;
Samore, Matthew H. ;
Seo, Susan K. ;
Trivedi, Kavita K. .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (10) :E51-E77
[3]   Using antibiotics responsibly: right drug, right time, right dose, right duration [J].
Dryden, Matthew ;
Johnson, Alan P. ;
Ashiru-Oredope, Diane ;
Sharland, Mike .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (11) :2441-2443
[4]  
Federal Bureau of Prisons, 2024, FEDERAL BUREAU PRISO
[5]   Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011 [J].
Fleming-Dutra, Katherine E. ;
Hersh, Adam L. ;
Shapiro, Daniel J. ;
Bartoces, Monina ;
Enns, Eva A. ;
File, Thomas M., Jr. ;
Finkelstein, Jonathan A. ;
Gerber, Jeffrey S. ;
Hyun, David Y. ;
Linder, Jeffrey A. ;
Lynfield, Ruth ;
Margolis, David J. ;
May, Larissa S. ;
Merenstein, Daniel ;
Metlay, Joshua P. ;
Newland, Jason G. ;
Piccirillo, Jay F. ;
Roberts, Rebecca M. ;
Sanchez, Guillermo V. ;
Suda, Katie J. ;
Thomas, Ann ;
Woo, Teri Moser ;
Zetts, Rachel M. ;
Hicks, Lauri A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (17) :1864-1873
[6]   Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits [J].
Kabbani, Sarah ;
Hersh, Adam L. ;
Shapiro, Daniel J. ;
Fleming-Dutra, Katherine E. ;
Pavia, Andrew T. ;
Hicks, Lauri A. .
CLINICAL INFECTIOUS DISEASES, 2018, 67 (01) :134-136
[7]   First-Line Antibiotic Selection in Outpatient Settings [J].
Palms, Danielle L. ;
Hicks, Lauri A. ;
Bartoces, Monina ;
Hersh, Adam L. ;
Zetts, Rachel ;
Hyun, David Y. ;
Fleming-Dutra, Katherine E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
[8]  
US Food and Drug Administration, FDA UPDATES WARNINGS
[9]  
US Food and Drug Administration, 2018, FDA REINFORCES SAFET
[10]  
US Food and Drug Administration, 2018, FDA WARNS INCREASED